Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00254072 · ClinicalTrials.gov registry record · NA

Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)

A NA study, sponsored by University of California, Irvine.

Completed
Registry status
NA
Development phase
355
Enrollment target

NCT00254072: Completed NA study, sponsored by University of California, Irvine.

NCT00254072 is a NA study that has completed, run by University of California, Irvine. The registered enrollment target is 355 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00254072, a NA study, has completed, sponsored by University of California, Irvine.

COMPLETED
Registry status
NA
Development phase
355 participants
Enrollment target

Study Summary

Laparoscopic gastric bypass surgery is a common procedure being performed for the treatment of morbid obesity. The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy. Potential complications after gastric bypass include gastrointestinal bleeding and leaks. Gastrointestinal bleeding can occur at any staple line including the gastrojejunostomy. Potential methods for prevention of postoperative gastrointestinal bleeding include oversewing of the anastomosis or the use of a smaller stapler height. We hypothesize that the use of staplers with smaller staple height will significantly result in a lower rate of staple line bleeding and possible leaks.

Interventions

  • PROCEDURE 3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass

Trial Details

FieldValue
Enrollment Target 355 participants
Start Date 2007-01
Est. Completion 2009-04
Phase NA
University of California, Irvine

368 total trials

What the finished NCT00254072 record still lists

NCT00254072 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which 3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass is the first listed.

NCT00254072 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00254072 about?

NCT00254072 is a clinical study titled "Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)". Laparoscopic gastric bypass surgery is a common procedure being performed for the treatment of morbid obesity. The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejuno...

What is the current status of trial NCT00254072?

This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2007-01. Estimated completion is 2009-04.

What interventions are being tested in trial NCT00254072?

The interventions under investigation include: 3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass (PROCEDURE).

Who is sponsoring clinical trial NCT00254072?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00254072's enrollment target sits among peer trials

355 291st of 2000 higher than 1,710 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07133308 · 355 participants · Phase 3

    Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

  • NCT07193511 · 355 participants · Phase 1

    BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

  • NCT06077838 · 356 participants · NA

    RELAXaHEAD for Headache Patients (Phase III)

  • NCT06293469 · 356 participants · NA

    Accelerated Flap Coverage in Severe Lower Extremity Trauma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00254072, the US trial registry maintained by the National Library of Medicine. NCT00254072 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.